EMA: Regulatory information - EMA clarifies interpretation of new variation classification categories

13.02.2014

The Commission guidelines on variations to marketing authorisations of medicinal products were amended in 2013. The revision of the variations guidelines was principally triggered by the implementation of the pharmacovigilance legislation.